St. Joseph's Hospital and Medical Center - Phoenix, Arizona Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Phoenix AZ United States (1895)

Organization Overview

First Clinical Trial
2012
NCT02085304
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Barrow Neurological Institute at St. Joseph's Hospital and Medical Center | Barrow Neurological Institute at St.Joseph's Hospital Medical Center | Barrow Neurological Institute/St. Joseph's Hospital and Medical Center | Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix AZ | St. Joseph's Hospital and Medical Center | St. Joseph's Hospital and Medical Center, Norton Thoracic Institute | St. Joseph's Hospital and Medical Center - Phoenix, Arizona

Active Ingredients

Drugs in Phase 4 Trials (3)

bupivacaine (Exparel) (1 trial)

dextromethorphan (delsym) (1 trial)

quinidine (1 trial)

Drugs in Phase 2 Trials (4)

carmustine (bicnu) (1 trial)

dianhydrogalactitol (1 trial)

droxidopa (northera) (1 trial)

temozolomide (temodar) (1 trial)

Drugs in Phase 1 Trials (1)

mk-1775 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 4)

Carcinoma, Ovarian Epithelial (Phase 2)

Glioblastoma (Phase 2)

Ovarian Neoplasms (Phase 2)

Parkinson Disease (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8